Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10347) 10347
Book Review (1550) 1550
Publication (1301) 1301
Newsletter (158) 158
Book Chapter (31) 31
Conference Proceeding (17) 17
Magazine Article (3) 3
Newspaper Article (2) 2
Dissertation (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8991) 8991
humans (5335) 5335
pharmacology & pharmacy (4164) 4164
amphotericin b - pharmacology (3878) 3878
antifungal agents - pharmacology (3716) 3716
amphotericin-b (3317) 3317
microbiology (3240) 3240
animals (3222) 3222
amphotericin b (2726) 2726
microbial sensitivity tests (2327) 2327
male (1978) 1978
antifungal agents - therapeutic use (1912) 1912
female (1749) 1749
infectious diseases (1612) 1612
mice (1432) 1432
fluconazole (1388) 1388
amphotericin b - therapeutic use (1373) 1373
voriconazole (1207) 1207
antifungal agents (1140) 1140
amphotericin b - administration & dosage (1088) 1088
candida - drug effects (1082) 1082
candida albicans - drug effects (1059) 1059
antifungal agents - administration & dosage (955) 955
adult (948) 948
in-vitro (897) 897
antiparasitic agents (888) 888
mycology (886) 886
fluconazole - pharmacology (882) 882
itraconazole (881) 881
middle aged (838) 838
candidiasis - drug therapy (836) 836
susceptibility (793) 793
mycoses - drug therapy (754) 754
drug resistance, fungal (688) 688
candida-albicans (668) 668
infections (661) 661
liposomal amphotericin-b (654) 654
resistance (636) 636
triazoles - pharmacology (630) 630
caspofungin (622) 622
fungal-infections (613) 613
therapy (597) 597
liposomes (595) 595
candidiasis - microbiology (589) 589
treatment outcome (583) 583
antifungal agents - pharmacokinetics (570) 570
pharmacokinetics (569) 569
infection (558) 558
aged (552) 552
dose-response relationship, drug (552) 552
echinocandins (544) 544
mycoses (542) 542
toxicity (537) 537
epidemiology (533) 533
itraconazole - pharmacology (532) 532
analysis (523) 523
aspergillosis - drug therapy (517) 517
health aspects (513) 513
research (500) 500
pharmacology (497) 497
drugs (496) 496
fungi (495) 495
candida (494) 494
drug synergism (488) 488
rats (485) 485
antifungal agents - chemistry (474) 474
immunology (468) 468
antifungal agents - adverse effects (467) 467
biochemistry & molecular biology (467) 467
efficacy (460) 460
lipopeptides (455) 455
drug therapy, combination (452) 452
time factors (448) 448
chemistry, medicinal (447) 447
candida albicans (439) 439
candidiasis (436) 436
aspergillosis (432) 432
flucytosine - pharmacology (431) 431
amphotericin b - adverse effects (427) 427
microbial sensitivity tests - methods (422) 422
echinocandins - pharmacology (418) 418
fungi - drug effects (418) 418
amphotericin b - chemistry (413) 413
adolescent (412) 412
invasive aspergillosis (410) 410
candida - isolation & purification (404) 404
drug resistance (396) 396
anti-bacterial agents - pharmacology (394) 394
antifungal activity (391) 391
disease models, animal (387) 387
pyrimidines - pharmacology (385) 385
antifungal (381) 381
child (378) 378
mice, inbred balb c (378) 378
visceral leishmaniasis (373) 373
amphotericin b - pharmacokinetics (371) 371
albicans (365) 365
antifungal susceptibility (364) 364
bacterial infections and mycoses (363) 363
aspergillus fumigatus - drug effects (361) 361
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9995) 9995
Spanish (120) 120
Russian (107) 107
Japanese (93) 93
French (75) 75
German (52) 52
Chinese (22) 22
Italian (22) 22
Portuguese (21) 21
Turkish (16) 16
Czech (5) 5
Polish (5) 5
Ukrainian (3) 3
Korean (2) 2
Croatian (1) 1
Dutch (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Comparison of EUCAST and CLSI reference microdilution mics of eight antifungal compounds for candida auris and associated tentative epidemiological cutoff values
by Arendrup, M.C and Prakash, Anupam and Meletiadis, Joseph and Sharma, Cheshta and Chowdhary, Anuradha
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2017, Volume 61, Issue 6
Candida auris is an emerging multidrug-resistant yeast. So far, all but two susceptibility testing studies have examined <= 50 isolates, mostly with the CLSI... 
Candida auris | Antifungal susceptibility testing | Azoles | Amphotericin b | Mic | Echinocandins | Ecoff | In vitro | ETEST | MIC | CLONAL STRAIN | MICROBIOLOGY | amphotericin B | AMPHOTERICIN-B | antifungal susceptibility testing | EMERGENCE | GENOME | HAEMULONII | BROTH MICRODILUTION | azoles | in vitro | echinocandins | RESISTANCE | PHARMACOLOGY & PHARMACY | ECOFF | INDIA | NOSOCOMIAL FUNGEMIA | Antifungal Agents - pharmacology | Microbial Sensitivity Tests | Lipopeptides - pharmacology | Amphotericin B - pharmacology | Candida - drug effects | Azoles - pharmacology | Echinocandins - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The emerging pathogen Candida auris: Growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation
by Larkin, Emily and Hager, Christopher and Chandra, Jyotsna and Mukherjee, Pranab K and Retuerto, Mauricio and Salem, Iman and Long, Lisa and Isham, Nancy and Kovanda, Laura and Borroto-Esoda, Katyna and Wring, Steve and Angulo, David and Ghannoum, Mahmoud
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2017, Volume 61, Issue 5
Candida auris, a new multidrug-resistant Candida spp. which is associated with invasive infection and high rates of mortality, has recently emerged. Here, we... 
Biofilm | SCY-078 | Candida auris | Virulence | CLONAL STRAIN | SUSCEPTIBILITY | MICROBIOLOGY | AMPHOTERICIN-B | SILICONE | IDENTIFICATION | HAEMULONII | YEAST | IN-VITRO | virulence | biofilm | PHARMACOLOGY & PHARMACY | ALBICANS | INDIA | Antifungal Agents - pharmacology | Biofilms - drug effects | Candida albicans - pathogenicity | Candida - growth & development | Fluconazole - pharmacology | Triterpenes - pharmacology | Glucans - biosynthesis | Drug Resistance, Multiple, Fungal | Humans | Amphotericin B - pharmacology | Biofilms - growth & development | Phospholipases - biosynthesis | Candida albicans - growth & development | Candidiasis - microbiology | Glycosides - pharmacology | Candida - isolation & purification | Cell Adhesion | Virulence Factors | Cell Division - drug effects | Peptide Hydrolases - biosynthesis | Microbial Sensitivity Tests | Candida - pathogenicity | Candidiasis - drug therapy | Candida - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Large-scale evaluation of In Vitro amphotericin B, triazole, and echinocandin activity against Coccidioides species from U.S. institutions
by Thompson, George R and Barker, Bridget M and Wiederhold, Nathan P
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2017, Volume 61, Issue 4
Large-scale testing of Coccidioides isolates has not been performed, and the frequency of clinical isolates with elevated amphotericin B or triazole MICs has... 
Antifungal susceptibility testing | Amphotericin B | Fluconazole | Coccidioidomycosis | Caspofungin | Voriconazole | Flucytosine | Coccidioides | Endemic mycoses | Posaconazole | Itraconazole | posaconazole | flucytosine | endemic mycoses | voriconazole | ANTIFUNGAL ACTIVITY | MORPHOLINE RING | MICROBIOLOGY | itraconazole | amphotericin B | caspofungin | antifungal susceptibility testing | SOCIETY-OF-AMERICA | CLINICAL-PRACTICE GUIDELINES | fluconazole | DIMORPHIC FUNGI | IMMITIS | AZOLE DERIVATIVES | MOUSE MODEL | coccidioidomycosis | PHARMACOLOGY & PHARMACY | REFRACTORY COCCIDIOIDOMYCOSIS | Antifungal Agents - pharmacology | Microbial Sensitivity Tests | Triazoles - pharmacology | Voriconazole - pharmacology | Coccidioidomycosis - microbiology | Lipopeptides - pharmacology | United States | Amphotericin B - pharmacology | Coccidioides - drug effects | Flucytosine - pharmacology | Echinocandins - pharmacology | Itraconazole - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds
by Katragkou, Aspasia and McCarthy, Matthew and Meletiadis, Joseph and Petraitis, Vidmantas and Moradi, Patriss W and Strauss, Gittel E and Fouant, Monique M and Kovanda, Laura L and Petraitiene, Ruta and Roilides, Emmanuel and Walsh, Thomas J
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2014, Volume 58, Issue 11, pp. 6934 - 6937
Whether isavuconazole, an extended-spectrum triazole, possesses synergistic activity in combination therapy with echinocandins or amphotericin B for the... 
ANTIFUNGAL TRIAZOLE | THERAPY | PHARMACOKINETICS | YEASTS | RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | FILAMENTOUS FUNGI | EXPERIMENTAL PULMONARY ASPERGILLOSIS | EPIDEMIOLOGY | VIVO CORRELATION | Antifungal Agents - pharmacology | Cunninghamella - drug effects | Nitriles - pharmacology | Lipopeptides - pharmacology | Amphotericin B - pharmacology | Aspergillus - drug effects | Microbial Sensitivity Tests | Triazoles - pharmacology | Deoxycholic Acid - pharmacology | Drug Interactions | Aspergillosis - microbiology | Pyridines - pharmacology | Mucormycosis - drug therapy | Drug Combinations | Echinocandins - pharmacology | Aspergillosis - drug therapy | Index Medicus | Pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts
by F. Sabatelli and R. Patel and P. A. Mann and C. A. Mendrick and C. C. Norris and R. Hare and D. Loebenberg and T. A. Black and P. M. McNicholas
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2006, Volume 50, Issue 6, pp. 2009 - 2015
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
UNITED-STATES | SCEDOSPORIUM | CANDIDA-ALBICANS | VIVO ACTIVITIES | TRIAZOLE | SUSCEPTIBILITIES | ANTIFUNGAL AGENTS | SURVEILLANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SCH 56592 | ASPERGILLUS SPP | Fluconazole - pharmacology | Cryptococcosis - microbiology | Humans | Mycoses - microbiology | Cryptococcus - genetics | Candidiasis - microbiology | Itraconazole - pharmacology | Microbial Sensitivity Tests | Voriconazole | Aspergillus - isolation & purification | Aspergillus - genetics | Drug Resistance, Fungal | Antifungal Agents - pharmacology | Candida - genetics | Fungi - drug effects | Amphotericin B - pharmacology | Pyrimidines - pharmacology | Candida - isolation & purification | Aspergillus - drug effects | Triazoles - pharmacology | Aspergillosis - microbiology | Cryptococcus - isolation & purification | Candida - drug effects | In Vitro Techniques | Cryptococcus - drug effects | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
by Mamiko Miyazaki and Takaaki Horii and Katsura Hata and Nao-aki Watanabe and Kazutaka Nakamoto and Keigo Tanaka and Syuji Shirotori and Norio Murai and Satoshi Inoue and Masayuki Matsukura and Shinya Abe and Kentaro Yoshimatsu and Makoto Asada
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2011, Volume 55, Issue 10, pp. 4652 - 4658
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
INFECTIONS | CANDIDA-ALBICANS | THERAPY | TESTING SUSCEPTIBILITIES | MICRODILUTION METHOD | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | AGENTS | AMPHOTERICIN-B | ITRACONAZOLE | EPIDEMIOLOGY | ASPERGILLUS | Fluconazole - pharmacology | Pseudallescheria - drug effects | Lipopeptides - pharmacology | Humans | Scedosporium - drug effects | Fusarium - drug effects | Paecilomyces - drug effects | Itraconazole - pharmacology | Microbial Sensitivity Tests | Voriconazole | Antifungal Agents - toxicity | Echinocandins - pharmacology | Antifungal Agents - pharmacology | Aminopyridines - toxicity | Cell Line | Fungi - drug effects | Amphotericin B - pharmacology | Pyrimidines - pharmacology | Yeasts - drug effects | Aspergillus - drug effects | Isoxazoles - pharmacology | Triazoles - pharmacology | Aminopyridines - pharmacology | Candida - drug effects | Isoxazoles - toxicity | Index Medicus | Toxicity | Antifungal agents | Molds | Cytotoxicity | Fungi | Infection | Antifungal activity | fluconazole | Amphotericin B | Minimum inhibitory concentration | micafungin | Itraconazole | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Antifungal Susceptibilities of the Species of the Pseudallescheria boydii Complex
by Fèlix Gilgado and Carolina Serena and Josep Cano and Josepa Gené and Josep Guarro
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2006, Volume 50, Issue 12, pp. 4211 - 4213
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
VORICONAZOLE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | AMPHOTERICIN-B | SCEDOSPORIUM-APIOSPERMUM | Fluconazole - pharmacology | Pseudallescheria - drug effects | Humans | Scedosporium - drug effects | Peptides, Cyclic - pharmacology | Itraconazole - pharmacology | Ketoconazole - pharmacology | Microbial Sensitivity Tests | Scedosporium - isolation & purification | Voriconazole | Drug Resistance, Fungal | Pseudallescheria - isolation & purification | Quality Control | Antifungal Agents - pharmacology | Amphotericin B - pharmacology | Pyrimidines - pharmacology | Micafungin | Terbinafine | Naphthalenes - pharmacology | Triazoles - pharmacology | Lipoproteins - pharmacology | Echinocandins | Thiazoles - pharmacology | Candida - drug effects | Flucytosine - pharmacology | Quinazolines - pharmacology | Lipopeptides | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi
by Manuel Cuenca-Estrella and Alicia Gomez-Lopez and Emilia Mellado and Maria J. Buitrago and Araceli Monzon and Juan Luis Rodriguez-Tudela
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2006, Volume 50, Issue 3, pp. 917 - 921
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
VORICONAZOLE | CASPOFUNGIN | POSACONAZOLE | IN-VITRO ACTIVITIES | CANDIDA | SUSCEPTIBILITIES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | AMPHOTERICIN-B | SCH 56592 | ITRACONAZOLE | ASPERGILLUS | Antifungal Agents - pharmacology | Fluconazole - pharmacology | Fungi - drug effects | Humans | Amphotericin B - pharmacology | Fungi - isolation & purification | Mycoses - microbiology | Peptides, Cyclic - pharmacology | Pyrimidines - pharmacology | Yeasts - drug effects | Itraconazole - pharmacology | Spain | Microbial Sensitivity Tests | Triazoles - pharmacology | Voriconazole | Echinocandins | Flucytosine - pharmacology | Yeasts - isolation & purification | Lipopeptides | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP
by Lempers, V.J and Heuvel, J.J.M.W. van den and Russel, F.G and Aarnoutse, R.E and Burger, D.M and Bruggemann, R.J and Koenderink, J.B
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 2016, Volume 60, Issue 6, pp. 3372 - 3379
Inhibition of ABC transporters is a common mechanism underlying drug-drug interactions (DDIs). We determined the inhibitory potential of antifungal drugs... 
PHARMACOKINETICS | BSEP/ABCB11 | HEALTHY-SUBJECTS | SALT EXPORT PUMP | SUBSTRATE | DIGOXIN | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | HUMAN LIVER | AGENTS | ITRACONAZOLE | ISAVUCONAZOLE | Antifungal Agents - pharmacology | Fluconazole - pharmacology | Voriconazole - pharmacology | Lipopeptides - pharmacology | Humans | Amphotericin B - pharmacology | Neoplasm Proteins - metabolism | ATP Binding Cassette Transporter, Sub-Family G, Member 2 - metabolism | Itraconazole - pharmacology | Triazoles - pharmacology | ATP Binding Cassette Subfamily B Member 11 | HEK293 Cells | ATP Binding Cassette Transporter, Sub-Family B - metabolism | ATP-Binding Cassette Transporters - metabolism | Biological Transport - drug effects | Itraconazole - analogs & derivatives | Multidrug Resistance-Associated Proteins - metabolism | Echinocandins - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii Isolates
by Ferry Hagen and Maria-Teresa Illnait-Zaragozi and Karen H. Bartlett and Daniëlle Swinne and Erik Geertsen and Corné H. W. Klaassen and Teun Boekhout and Jacques F. Meis
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2010, Volume 54, Issue 12, pp. 5139 - 5145
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
UNITED-STATES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | NEOFORMANS | PACIFIC-NORTHWEST | HYBRID | Antifungal Agents - pharmacology | Fluconazole - pharmacology | Nitriles - pharmacology | Humans | Amphotericin B - pharmacology | Genotype | Pyrimidines - pharmacology | Cryptococcus gattii - drug effects | Microbial Sensitivity Tests | Triazoles - pharmacology | Cryptococcus gattii - isolation & purification | Animals | Environmental Microbiology | Voriconazole | Cryptococcus gattii - genetics | Pyridines - pharmacology | Flucytosine - pharmacology | Amplified Fragment Length Polymorphism Analysis | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Identification and Characterization of Four Azole-Resistant erg3 Mutants of Candida albicans
by Claire M. Martel and Josie E. Parker and Oliver Bader and Michael Weig and Uwe Gross and Andrew G. S. Warrilow and Nicola Rolley and Diane E. Kelly and Steven L. Kelly
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2010, Volume 54, Issue 11, pp. 4527 - 4533
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CONTRIBUTE | IN-VIVO | ANTIFUNGAL AGENTS | AMINO-ACID SUBSTITUTIONS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MECHANISMS | AMPHOTERICIN-B | MUTATIONS | FLUCONAZOLE RESISTANCE | SACCHAROMYCES-CEREVISIAE | AIDS PATIENTS | Antifungal Agents - pharmacology | Fluconazole - pharmacology | Ergosterol - metabolism | Oxidoreductases - genetics | Amphotericin B - pharmacology | Clotrimazole - pharmacology | Candida albicans - metabolism | Drug Resistance, Fungal - genetics | Pyrimidines - pharmacology | Azoles - pharmacology | Itraconazole - pharmacology | Ketoconazole - pharmacology | Candida albicans - genetics | Microbial Sensitivity Tests | Triazoles - pharmacology | Candida albicans - drug effects | Voriconazole | Mutation | Index Medicus | Mechanisms of Resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Candida auris candidaemia in Indian ICUs: Analysis of risk factors
by Rudramurthy, Shivaprakash M and Chakrabarti, Arunaloke and Paul, Raees A and Sood, Prashant and Kaur, Harsimran and Capoor, Malini R and Kindo, Anupma J and Marak, Rungmei S.K and Arora, Anita and Sardana, Raman and Das, Shukla and Chhina, Deepinder and Patel, Atul and Xess, Immaculata and Tarai, Bansidhar and Singh, Pankaj and Ghosh, Anup
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 6, pp. 1794 - 1801
Objectives: To identify the risk factors associated with Candida auris candidaemia, as this fungus now poses a global threat. Methods: We performed a subgroup... 
CLSI | INFECTIOUS DISEASES | INFECTIONS | CLONAL STRAIN | MICROBIOLOGY | ANTIFUNGAL SUSCEPTIBILITY | IDENTIFICATION | HAEMULONII | VARIABILITY | DELHI | FLIGHT MASS-SPECTROMETRY | DESORPTION IONIZATION-TIME | PHARMACOLOGY & PHARMACY | Fluconazole - pharmacology | Lipopeptides - pharmacology | Humans | Middle Aged | Male | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Young Adult | Candida - classification | Adult | Female | Echinocandins - pharmacology | Mycological Typing Techniques | Antifungal Agents - pharmacology | Candidemia - microbiology | Intensive Care Units | Risk Factors | Amphotericin B - pharmacology | India - epidemiology | Candidemia - epidemiology | Candida - isolation & purification | Candida - pathogenicity | Candidemia - drug therapy | Adolescent | Aged | Candida - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text In vitro interactions between farnesol and fluconazole, amphotericin b or micafungin against candida albicans biofilms
by Katragkou, Aspasia and Mccarthy, Matthew and Alexander, Elizabeth L and Antachopoulos, Charalampos and Meletiadis, Joseph and Jabra-rizk, Mary Ann and Petraitis, Vidmantas and Roilides, Emmanuel and Walsh, Thomas J
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 02/2015, Volume 70, Issue 2, pp. 470 - 478
Objectives: Biofilm formation by Candida albicans poses an important therapeutic challenge in human diseases. Typically, conventional antifungal agents... 
Antifungals | C. albicans | Combinations | INFECTIOUS DISEASES | RAS | SUSCEPTIBILITY | MICROBIOLOGY | antifungals | MORPHOGENESIS | combinations | PATHWAY | MOUSE MODEL | ANTIFUNGAL AGENTS | RESISTANCE | PHARMACOLOGY & PHARMACY | QUORUM-SENSING MOLECULE | TRANSCRIPTIONAL RESPONSE | Antifungal Agents - pharmacology | Biofilms - drug effects | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Microscopy, Confocal | Fluconazole - pharmacology | Candida albicans - drug effects | Drug Interactions | Farnesol - pharmacology | Humans | Amphotericin B - pharmacology | Candida albicans - physiology | Proteins | Antimicrobial agents | Biofilms | Organic chemicals | Metabolism | Biological assays | Index Medicus | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
by Marieke Vermeersch and Raquel Inocêncio da Luz and Kim Toté and Jean-Pierre Timmermans and Paul Cos and Louis Maes
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2009, Volume 53, Issue 9, pp. 3855 - 3859
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
PENTAVALENT ANTIMONY | VIVO | MILTEFOSINE | RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | KALA-AZAR | AMPHOTERICIN-B | SODIUM STIBOGLUCONATE | AXENIC AMASTIGOTES | VISCERAL LEISHMANIASIS | CULTIVATION | Microscopy, Electron, Transmission | Parasitic Sensitivity Tests | Triterpenes - pharmacology | Leishmania donovani - drug effects | Triterpenes - therapeutic use | Amphotericin B - pharmacology | Cells, Cultured | Leishmania donovani - ultrastructure | Leishmaniasis - drug therapy | Phosphorylcholine - analogs & derivatives | Antiprotozoal Agents - pharmacology | Leishmania donovani - growth & development | Animals | Phosphorylcholine - pharmacology | Antimony Sodium Gluconate - pharmacology | Inhibitory Concentration 50 | Saponins - therapeutic use | Mice | Saponins - pharmacology | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text In Vitro Susceptibility of Aspergillus fumigatus to Isavuconazole: Correlation with Itraconazole, Voriconazole, and Posaconazole
by Lea Gregson and Joanne Goodwin and Adam Johnson and Laura McEntee and Caroline B. Moore and Malcolm Richardson and William W. Hope and Susan J. Howard
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2013, Volume 57, Issue 11, pp. 5778 - 5780
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
BAL4815 | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PATIENT | AZOLE RESISTANCE | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Nitriles - pharmacology | Humans | Amphotericin B - pharmacology | Cytochrome P-450 Enzyme System - metabolism | Drug Resistance, Fungal - genetics | Fungal Proteins - genetics | Pyrimidines - pharmacology | Aspergillus fumigatus - genetics | Itraconazole - pharmacology | Microbial Sensitivity Tests | Triazoles - pharmacology | Voriconazole | Cytochrome P-450 Enzyme System - genetics | Aspergillus fumigatus - growth & development | Aspergillus fumigatus - metabolism | Pyridines - pharmacology | Mutation | Amino Acid Substitution | Fungal Proteins - metabolism | Index Medicus | Amphotericin B | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms
by Delattin, Nicolas and De Brucker, Katrijn and Vandamme, Katleen and Meert, Els and Marchand, Arnaud and Chaltin, Patrick and Cammue, Bruno P. A and Thevissen, Karin
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 4/2014, Volume 69, Issue 4, pp. 1035 - 1044
Objectives Biofilms of Candida species, often formed on medical devices, are generally resistant to currently available antifungal drugs. The aim of this study... 
Yeast | Drug synergy | Toremifene citrate | Antifungal agents | INFECTIOUS DISEASES | ANTICANCER DRUG TAMOXIFEN | INFECTIONS | antifungal agents | CLINICAL-TRIAL | MICROBIOLOGY | ANTIFUNGAL SUSCEPTIBILITY | yeast | CAENORHABDITIS-ELEGANS | toremifene citrate | PROSTATE-CANCER | drug synergy | DOUBLE-BLIND | SURFACE | RESISTANCE | PHARMACOLOGY & PHARMACY | EPIDEMIOLOGY | Antifungal Agents - pharmacology | Biofilms - drug effects | Caenorhabditis elegans - microbiology | Osteoblasts - drug effects | Osteoblasts - physiology | Amphotericin B - pharmacology | Perhexiline - pharmacology | Androstenes - pharmacology | Drug Repositioning | Drug Synergism | Microbial Sensitivity Tests | Animals | Candida albicans - drug effects | Candida albicans - physiology | Lipopeptides | Perhexiline - analogs & derivatives | Echinocandins - pharmacology | Toremifene - pharmacology | Fungi | Gram-positive bacteria | Biofilms | Inhibitor drugs | Drug resistance | Biological activity | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights